INIS
aggregation
13%
applications
10%
assessments
17%
atherosclerosis
17%
biological markers
29%
blood
16%
comparative evaluations
36%
concentration
27%
copper oxides
11%
covid-19
34%
cytokines
11%
data
19%
detection
11%
dexamethasone
11%
doses
13%
drugs
14%
electrochemistry
13%
hemolysis
13%
humans
34%
immunoglobulins
11%
in vitro
35%
inflammation
20%
interlaboratory comparisons
11%
investigations
16%
kinases
91%
matrices
13%
metabolites
11%
molecules
12%
myeloid leukemia
63%
nanopowders
22%
neutrophils
12%
nucleosomes
11%
patients
100%
performance
15%
plasma
24%
proteins
32%
reviews
34%
risks
61%
ruptures
11%
safety
11%
sensitivity
17%
shells
11%
standardization
13%
steroids
15%
thrombin
28%
thrombosis
13%
tyrosine
91%
validation
11%
women
16%
wounds
18%
Medicine and Dentistry
Activated Protein C Resistance
11%
Acute Leukemia
11%
APC
6%
Artery Thrombosis
12%
Biological Marker
11%
Cell Function
11%
Cell Survival
11%
Chronic Myelogenous Leukemia
24%
Contraceptive Agent
11%
Dasatinib
18%
Disseminated Intravascular Coagulation
11%
Endothelial Cell
22%
Imatinib
10%
Immunoglobulin G
11%
Immunoglobulin M
11%
In Vitro
22%
Independent Reviewer
5%
Meta-Analysis
11%
Nilotinib
12%
Ponatinib
15%
Procoagulant
11%
Systematic Review
11%
Thrombin
14%
Thrombosis
11%
Tyrosine-Kinase Inhibitor
34%
Keyphrases
Antifungal Properties
11%
Arterial Events
8%
Atherosclerosis Plaque
11%
BCR-ABL Inhibitors
11%
Chronic Myeloid Leukemia
11%
Clinical Investigation
11%
Coagulation Properties
11%
Contraceptives
11%
COVID-19 Shocks
11%
Critical COVID-19
11%
Cuprite
5%
Cytokine Response
11%
Efficacy Biomarkers
11%
Human Blood
11%
Inorganic Nanotubes
11%
Leukemia Patients
11%
Major Molecular Response
11%
Oxide Nanopowders
11%
Plaque Rupture
11%
Regulatory Needs
11%
Resistance Test
11%
Safety Profile
11%
Surrogate Biomarkers
5%
Unmet Medical Need
11%
Vascular Occlusive Events
8%
Vascular Safety
11%
Wound Dressing
11%